Home › Regeneron Pharmaceuticals PT Raised to $344.00
 

Keywords :   


Regeneron Pharmaceuticals PT Raised to $344.00

2013-12-22 08:42:25| Biotech - Topix.net

The firm currently has an "outperform" rating on the stock. RBC Capital's price target would indicate a potential upside of 23.43% from the company's current price.

Tags: raised pharmaceuticals regeneron regeneron pharmaceuticals

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Eastern North Pacific Tropical Weather Outlook
28.09Atlantic Tropical Weather Outlook
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Public Advisory Number 5
28.09Summary for Tropical Storm Joyce (AT1/AL112024)
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Forecast Discussion Number 5
28.09Tropical Storm Joyce Wind Speed Probabilities Number 5
More »